Immunome IMNM
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 21.48 | 104.24 | -0.75 | -72,861 | -70 | |
| 2025Q3 | 11.71 | 104.67 | -0.66 | -60,138 | -57 | |
| 2025Q2 | 9.30 | 107.10 | -0.50 | -46,478 | -43 | |
| 2025Q1 | 6.73 | 107.20 | -0.52 | -44,636 | -42 | |
| 2024Q4 | 10.62 | 103.39 | -1.28 | -82,970 | -80 | |
| 2024Q3 | 14.62 | 107.27 | -0.75 | -50,522 | -47 | |
| 2024Q2 | 12.10 | 110.76 | -0.46 | -40,009 | -36 | |
| 2024Q1 | 24.68 | 102.17 | -2.51 | -132,299 | -129 | |
| 2023Q4 | 10.70 | 102.18 | -4.22 | -94,653 | -93 | |
| 2023Q3 | 8.35 | 106.63 | -0.35 | -4,633 | -4 | |
| 2023Q2 | 7.91 | 103.89 | -0.46 | -5,773 | -6 | |
| 2023Q1 | 4.99 | 104.71 | -0.35 | -4,471 | -4 | |
| 2022Q4 | 2.21 | 99.95 | -0.64 | -7,787 | -8 | |
| 2022Q3 | 4.44 | 99.96 | -0.75 | -8,534 | -9 | |
| 2022Q2 | 3.21 | 99.99 | -0.74 | -8,926 | -9 | |
| 2022Q1 | 5.68 | -0.96 | -11,654 | -12 | ||
| 2021Q4 | 12.96 | 99.96 | -0.65 | -7,844 | -8 | |
| 2021Q3 | 24.35 | 100.08 | -0.66 | -7,723 | -8 | |
| 2021Q2 | 17.30 | -0.46 | -5,740 | -5 | ||
| 2021Q1 | 33.88 | -0.37 | -3,897 | -4 |